Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Total Non-Current Liabilities (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Total Non-Current Liabilities for 9 consecutive years, with $126.1 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 6.34% to $126.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $126.1 million through Dec 2025, up 6.34% year-over-year, with the annual reading at $126.1 million for FY2025, 6.34% up from the prior year.
  • Total Non-Current Liabilities hit $126.1 million in Q4 2025 for Inspire Medical Systems, down from $141.1 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $141.1 million in Q3 2025 to a low of $50.2 million in Q1 2021.
  • Historically, Total Non-Current Liabilities has averaged $86.4 million across 5 years, with a median of $89.5 million in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 114.55% in 2021 and later decreased 2.22% in 2022.
  • Year by year, Total Non-Current Liabilities stood at $65.9 million in 2021, then grew by 4.28% to $68.7 million in 2022, then soared by 49.81% to $103.0 million in 2023, then rose by 15.14% to $118.5 million in 2024, then rose by 6.34% to $126.1 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for INSP at $126.1 million in Q4 2025, $141.1 million in Q3 2025, and $124.3 million in Q2 2025.